{"id":1403402,"title":"Résumé de recherche du RIEM : Modes de prescription de la ranitidine, de la nizatidine, de la famotidine et de la cimétidine au Canada - IRSC","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"fr","captureDate":"2026-04-14","captureTimestamp":"2026-04-14T16:43:10.340000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/f/52735.html","snippet":"Résumé de recherche du RIEM Modes de prescription de la ranitidine, de la nizatidine, de la famotidine et de la cimétidine au Canada En 2019, certains lots de ranitidine, un antagoniste des récepteurs H2 de l’histamine facilement accessible qui agit sur l’acidité de l’estomac,…","rawSnapshotUrl":"/api/snapshots/raw/1403402","browseUrl":"https://replay.healtharchive.ca/job-8/20260414164310/https://cihr-irsc.gc.ca/f/52735.html#ha_snapshot=1403402","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}